Literature DB >> 28128808

[Prevalence of non-nutritive sweeteners consumption in a population of patients with diabetes in Mexico].

Alonso Romo-Romo1, Paloma Almeda-Valdés1, Griselda X Brito-Córdova1, Francisco J Gómez-Pérez1.   

Abstract

OBJECTIVE: To estimate the prevalence of non-nutritive sweeteners (NNS) consumption in a sample of patients with diabetes.
MATERIAL AND METHODS: We applied two questionnaires, one of food frequency adapted to products containing NNS and the other of beliefs related to NNS. The prevalence of NNS consumption was determined and correlated with the body mass index, energy and sugar consumption, waist circumference, glycated hemoglobin, triglycerides, diabetes type, education and socioeconomic status.
RESULTS: The prevalence of NNS consumption was 96%; the consumption was greater in men and in patients with type 1 diabetes. A negative correlation was found between the consumption and age and a positive correlation with glycated hemoglobin and education.
CONCLUSIONS: The prevalence of NNS consumption is high due to the great availability of products in the market.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28128808

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  2 in total

1.  Diet-Quality and Socio-Demographic Factors Associated with Non-Nutritive Sweetener Use in the Australian Population.

Authors:  Amanda Grech; Chi On Kam; Luke Gemming; Anna Rangan
Journal:  Nutrients       Date:  2018-06-27       Impact factor: 5.717

2.  Is a Non-Caloric Sweetener-Free Diet Good to Treat Functional Gastrointestinal Disorder Symptoms? A Randomized Controlled Trial.

Authors:  Viridiana Montsserrat Mendoza-Martínez; Mónica Rocío Zavala-Solares; Aranza Jhosadara Espinosa-Flores; Karen Lorena León-Barrera; Raúl Alcántara-Suárez; José Damián Carrillo-Ruíz; Galileo Escobedo; Ernesto Roldan-Valadez; Marcela Esquivel-Velázquez; Guillermo Meléndez-Mier; Nallely Bueno-Hernández
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.